Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00375388
Status:
COMPLETED
Last Update Posted:
2006-09-13
First Post:
2006-09-12
Brief Title:
The HOME Trial Hyperinsulinaemia the Outcome of Its Metabolic Effects a Randomized Controlled Trial
Sponsor:
Bethesda General Hospital Hoogeveen
Organization:
Bethesda General Hospital Hoogeveen
Organization Data
Organization:
Bethesda General Hospital Hoogeveen
Class:
OTHER
Study ID:
METNL9701
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bethesda General Hospital Hoogeveen
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novo Nordisk AS | INDUSTRY |
| Takeda | INDUSTRY |
| LifeScan | INDUSTRY |
| Merck KGaA Darmstadt Germany | INDUSTRY |
| Dupont Merck | INDUSTRY |
| Merck Sharp Dohme LLC | INDUSTRY |